Abbvie Inc at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. Biopharma Analyst here at Morgan Stanley. Very pleased to be hosting AbbVie this morning for the session. Today, joining us from the company, we have Rob Michael, President and COO; Scott Reents, who's CFO; Jeff Stewart, CCO; and Roopal Thakkar, who is Head of Development and Regulatory Affairs and CMO. But thank you so much all for being here. Really appreciate the time.
Thanks for having us.
Before we get started for disclosures, please see Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. With that out of the way. Maybe Rob will go over
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |